Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | ubiquitin-activating enzyme E1 | 0.0186 | 0.0889 | 0.3004 |
Schistosoma mansoni | clathrin coat associated protein ap-50 | 0.0129 | 0.0402 | 0.0361 |
Trypanosoma cruzi | ubiquitin activating enzyme, putative | 0.0397 | 0.2671 | 1 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1 X, putative | 0.0088 | 0.0056 | 0.0053 |
Trypanosoma cruzi | ubiquitin-activating enzyme E1, putative | 0.0116 | 0.0293 | 0.1099 |
Loa Loa (eye worm) | ube1-prov protein | 0.0186 | 0.0889 | 0.0851 |
Toxoplasma gondii | hypothetical protein | 0.0096 | 0.0124 | 0.0082 |
Trypanosoma cruzi | ubiquitin-activating enzyme E1, putative | 0.0116 | 0.0293 | 0.1099 |
Trypanosoma brucei | ubiquitin-activating enzyme E1, putative | 0.0116 | 0.0293 | 0.0955 |
Leishmania major | ubiquitin activating enzyme, putative | 0.0397 | 0.2671 | 1 |
Plasmodium falciparum | NEDD8-activating enzyme E1 catalytic subunit, putative | 0.0397 | 0.2671 | 1 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1, putative | 0.0152 | 0.0601 | 0.0829 |
Giardia lamblia | Ubiquitin-conjugating enzyme E1 | 0.0116 | 0.0293 | 0.5 |
Echinococcus granulosus | ubiquitin modifier activating enzyme 6 | 0.0186 | 0.0889 | 0.0851 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1, putative | 0.0152 | 0.0601 | 0.0829 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1, putative | 0.0913 | 0.7041 | 1 |
Echinococcus granulosus | ubiquitin modifier activating enzyme 1 | 0.0186 | 0.0889 | 0.0851 |
Leishmania major | ubiquitin-activating enzyme e1, putative | 0.0093 | 0.0095 | 0.02 |
Schistosoma mansoni | clathrin coat associated protein ap-50 | 0.0129 | 0.0402 | 0.0361 |
Trypanosoma brucei | NEDD8 activating enzyme subunit, putative | 0.0397 | 0.2671 | 1 |
Trypanosoma cruzi | ubiquitin activating enzyme, putative | 0.0397 | 0.2671 | 1 |
Entamoeba histolytica | ubiquitin-activating enzyme, putative | 0.0186 | 0.0889 | 0.0851 |
Plasmodium vivax | ubiquitin-activating enzyme E1C, putative | 0.0397 | 0.2671 | 1 |
Echinococcus granulosus | NEDD8 activating enzyme E1 catalytic subunit | 0.1263 | 1 | 1 |
Loa Loa (eye worm) | ectopic membrane ruffles in embryo protein 1 | 0.1263 | 1 | 1 |
Schistosoma mansoni | ubiquitin-activating enzyme E1C | 0.1263 | 1 | 1 |
Echinococcus multilocularis | NEDD8 activating enzyme E1 catalytic subunit | 0.1263 | 1 | 1 |
Schistosoma mansoni | sumo-1-activating enzyme E1a | 0.0096 | 0.0124 | 0.0082 |
Entamoeba histolytica | ubiquitin-activating enzyme E1 1, putative | 0.0152 | 0.0601 | 0.0561 |
Echinococcus granulosus | SUMO activating enzyme subunit 1 | 0.0096 | 0.0124 | 0.0082 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1, putative | 0.0086 | 0.0042 | 0.0034 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1c, putative | 0.0152 | 0.0601 | 0.0829 |
Brugia malayi | ube1-prov protein | 0.0186 | 0.0889 | 0.0851 |
Echinococcus multilocularis | ubiquitin modifier activating enzyme 6 | 0.0186 | 0.0889 | 0.0851 |
Trypanosoma brucei | ubiquitin-activating enzyme E1, putative | 0.0093 | 0.0095 | 0.02 |
Leishmania major | ubiquitin-activating enzyme e1, putative | 0.0116 | 0.0293 | 0.0955 |
Brugia malayi | ThiF family protein | 0.0096 | 0.0124 | 0.0082 |
Toxoplasma gondii | NEDD8-activating enzyme E1 catalytic subunit | 0.1263 | 1 | 1 |
Schistosoma mansoni | ubiquitin-activating enzyme E1 | 0.0157 | 0.064 | 0.06 |
Trichomonas vaginalis | molybdopterin biosynthesis moeb protein, putative | 0.0397 | 0.2671 | 0.3777 |
Trypanosoma cruzi | NEDD8-activating enzyme E1 regulatory subunit, putative | 0.0086 | 0.0042 | 0.0159 |
Loa Loa (eye worm) | hypothetical protein | 0.0096 | 0.0124 | 0.0082 |
Echinococcus multilocularis | ubiquitin modifier activating enzyme 1 | 0.0186 | 0.0889 | 0.0851 |
Echinococcus multilocularis | SUMO activating enzyme subunit 1 | 0.0096 | 0.0124 | 0.0082 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1, putative | 0.0086 | 0.0042 | 0.0034 |
Entamoeba histolytica | ubiquitin-activating enzyme, putative | 0.1263 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.